https://www.selleckchem.com/products/peg400.html
Additionally, there were no differences in the gestational age at delivery, percentage of preterm delivery before 34 weeks and 37 weeks, pregnancy outcomes, neonatal outcomes, compliance and side effects. However, the time to the recurrence of uterine contractions in participants that had recurrent preterm labor waslonger in the dydrogesterone group than in the placebo group (30.6 ± 12.3 vs 13.7 ± 5.0 days, p = 0.01). Adjunctive treatment with 30mg of oral dydrogesterone could not prolong latency period in preterm labor when compared to
Gefällt mir
Kommentar
Teilen
